학술논문
23P CDK4/6 inhibition and endocrine therapy (ET) in the HER2-enriched subtype (HER2-E) in hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer (ABC): A retrospective analysis of real-world data
Document Type
Abstract
Author
Martínez-Sáez, O.; Tolosa, P.; Sánchez De Torre, A.; Pascual, T.; Brasó-Maristany, F.; Rodriguez Hernandez, A.; Parrilla, L.; Roncero, A.M.; Ruano, Y.; Chic, N.; Schettini, F.; Laguna, J.C.; Sanfeliu Torres, E.; Gonzalez-Farre, B.; Vidal, M.; Adamo, B.; Guillen Sacoto, M.C.; Muñoz, M.; Prat, A.; Ciruelos, E.M.
Source
In Annals of Oncology May 2021 32 Supplement 2:S30-S30
Subject
Language
ISSN
0923-7534